Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • New York guideNew York Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFQRFQ Meaning: What Is an RFQ?
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›New York
  4. ›Healthcare and Medical Services
  5. ›Neurostimulation Catheter For Neurogenic Dysphagia

State University of New York (SUNY)·New York

Neurostimulation Catheter For Neurogenic Dysphagia

Closes 12/15/2025$50k – $125kRequest for QuotationLogin required
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

Stony Brook University Hospital intends to purchase neurostimulation catheters and related items manufactured by Phagenesis under its discretionary authority, pursuant to NYS Education Law §355(5)(A), which is up to $125,000, for the above noted commodity/product or service. A sealed bid will not be held. If you are interested in providing a proposal for the above commodity/product or service, you must contact the appropriately designated Campus contact in this advertisement within 15 business days of this Advertisement Notice. This procurement is subject to NYS Finance Law §139 j&k, AKA the Lobbying Law. Therefore, vendors are cautioned that the only permissible contact for this procurement is the individual listed below. Failure to comply with this requirement can range from no contract to debarment from sales to any NYS Agency. Successful contractor shall be required to complete and submit documents related to Vendor Responsibility, NYS Finance Law 139, NYS Tax Law Section 5-a, and valid/current NYS Workers’ Compensation and Disability Forms. Business enterprises awarded an identical or substantially similar procurement contract within the past five years: None

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Deborah Hooper(Procurement Officer)

[email protected]

(631) 444-4060

Key dates

Opened
11/21/2025
Closes
12/15/2025

Last updated

Details

Type
Request for Quotation
Industry
Healthcare and Medical Services
NAICS
334510
Solicitation №
Q25-095

Budget estimate

$50,000 – $125,000

The estimated budget for this opportunity is between $50,000 and $125,000, as the procurement is being conducted under discretionary authority with a budget of up to $125,000. The actual budget may vary depending on the quotes received from interested parties. Factors that may influence the likely payment range include the number of quotes received, the complexity of the procurement, and the availability of funds.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 67%

Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/12/2021

U.S. National Institutes of Health·United States of America

66% match

BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2029Opened 8/28/2025

U.S. National Institutes of Health·United States of America

65% match

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

Closes 1/27/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

65% match

Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/12/2021

U.S. National Institutes of Health·United States of America

65% match

BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

65% match

BRAIN Initiative: Development and Validation of Novel Tools and New Approaches for Neuroscience Research

Closes 6/9/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

64% match

BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)

Closes 1/28/2027Opened 3/19/2024

U.S. National Institutes of Health·United States of America

64% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

U.S. National Institutes of Health·United States of America

64% match

BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)

Closes 10/6/2028Opened 5/9/2025

U.S. National Institutes of Health·United States of America

64% match

Translational Neural Devices (R61/R33 - Clinical Trial Optional)

Closes 1/28/2027Opened 2/23/2024

U.S. National Institutes of Health·United States of America

64% match

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. Department Of Health And Human Services·District of Columbia

63% match

Brain Repair of Any Injured Neural Structure (BRAINS)

Closes 2/26/2027Opened 6/8/2026

U.S. National Institutes of Health·United States of America

63% match

Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)

Closes 1/28/2028Opened 5/5/2025

U.S. National Institutes of Health·United States of America

63% match

Limited Competition: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships

Closes 6/16/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

63% match

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)

Closes 10/25/2027Opened 1/15/2025

U.S. National Institutes of Health·United States of America

63% match

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

Closes 11/8/2027Opened 5/22/2025

U.S. Department Of Health And Human Services·District of Columbia

63% match

Brain Repair of Any Injured Neural Structure (BRAINS)

Closes 2/26/2027Opened 7/2/2026

U.S. National Institutes of Health·United States of America

62% match

BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)

Closes 6/15/2027Opened 10/23/2024

U.S. National Institutes of Health·United States of America

62% match

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2027Opened 6/16/2023

U.S. National Institutes of Health·United States of America

62% match

BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)

Closes 10/4/2027Opened 8/26/2024

U.S. National Institutes of Health·United States of America

62% match

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

62% match

Single Source: Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Data Resource and Administrative Coordination Center (U24 Clinical Trial Not Allowed)

Closes 5/31/2027Opened 9/16/2026

U.S. National Institutes of Health·United States of America

62% match

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

62% match

Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

Closes 10/8/2027Opened 12/18/2024

U.S. National Institutes of Health·United States of America

62% match

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Closes 8/18/2027Opened 10/1/2024